## ISRG: Intuitive Surgical, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -1.9% below STRENGTH zone (4.0-10.0%); PEG 2.79 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($541.83)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Marshall Wace LLP Has $79.30 Million Position in Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251206T110804 | Somewhat-Bullish | Relevance: 99%
-  Marshall Wace LLP significantly increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 78% in Q2, bringing its stake to $79.30 million. Wall Street analysts maintain a largely bullish outlook on ISRG, with a "Moderate Buy" consensus and an average price target of $607.17. Despite insider selling totaling approximately $60.76 million recently, institutional investors collectively own 83.64% of the company's stock.

**2. Specialty Stocks Q3 Earnings: Intuitive Surgical (NASDAQ:ISRG) Best of the Bunch**
- Source: Finviz | 20251208T095557 | Bullish | Relevance: 99%
-  Intuitive Surgical led the specialty surgical equipment sector in Q3 earnings, surpassing analyst expectations with 22.9% year-on-year revenue growth. Other companies like Teleflex had mixed results, while Integra LifeSciences and LeMaitre showed weaker performance, missing estimates and experiencing stock declines. Overall, the sector's revenues and guidance aligned with consensus, with share prices up 1.4% on average.

**3. Jump Financial LLC Purchases 8,815 Shares of Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251207T114325 | Bullish | Relevance: 99%
-  Jump Financial LLC increased its stake in Intuitive Surgical, Inc. by 16.8%, acquiring an additional 8,815 shares, bringing their total holdings to 61,379 shares valued at approximately $33.35 million. This move is part of a broader trend of increased institutional investment in ISRG, with major entities like Norges Bank and Vanguard Group significantly expanding their positions. Intuitive Surgical, Inc. recently exceeded quarterly earnings estimates and maintains a "Moderate Buy" consensus rating from Wall Street analysts, with an average price target reflecting confidence in its continued growth.

**4. Winslow Capital Management LLC Grows Stock Position in Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251208T132524 | Somewhat-Bullish | Relevance: 99%
-  Winslow Capital Management LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.2% in Q2, making it their 13th largest holding. Despite this institutional accumulation, company insiders, including CEO Gary S. Guthart and EVP Henry L. Charlton, sold significant portions of their shares, totaling approximately $60.8 million. Intuitive Surgical recently surpassed Q3 earnings and revenue expectations, and the stock currently holds a "Moderate Buy" consensus rating from analysts with a target price of $607.17.

**5. Ossiam Has $27.44 Million Position in Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251208T115125 | Somewhat-Bullish | Relevance: 99%
-  Ossiam significantly increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 249.1% in Q2, boosting its holdings to 50,493 shares valued at approximately $27.44 million. Despite substantial recent insider selling, including CEO Gary S. Guthart's $13.02 million stock sale, Intuitive Surgical outperformed earnings expectations and maintains a "Moderate Buy" consensus rating from analysts with a target price of $607.17. Institutional investors currently own 83.64% of the medical equipment provider's stock.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 5 ($4.83M) |
| Sells | 10 ($1.12M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.6% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.4% (+0.8%)
- Blackrock Inc.: 8.8% (+0.1%)
- State Street Corpora: 4.3% (-0.1%)
- Price (T.Rowe) Assoc: 3.6% (-4.4%)
- Geode Capital Manage: 2.3% (+1.0%)

### Key Risks

1. Premium valuation (P/E 58x, PEG 2.8x) vulnerable to multiple compression.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.79 signals overvaluation risk, limited margin of safety. Forward P/E 58.3x stretched relative to 13% growth. Quality metrics strong (margin 29%). Balance sheet: strong liquidity (4.7x), low leverage (D/E 0.14). Insider buying signal ($4.8M), management confidence. Institutional flow bearish (4 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $203.2B |
| Beta | 1.69 |
| 52W Range | $425.00 - $616.00 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.79 |
| Forward P/E | 58.3 |
| Current P/E | 65.7 |
| YoY Growth | 12.7% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from -0.7% to -1.9% (-1.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.8pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-2.82), momentum weakening. RSI neutral at 58.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.85% (CS: 41) | Neutral |
| RSI_14 | 57.7 | Neutral |
| MACD Histogram | -2.82 | Bearish |
| vs SMA20 | 1.002x | Above |
| vs SMA50 | 1.093x | Above |
| vs SMA200 | 1.115x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $566.89
- **Stop Loss:** $541.83 (4.4% risk)
- **Target:** $591.95 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 19
- **Position Value:** $10,770.91
- **Portfolio %:** 10.77%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-01-22 (Est: $2.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.99 | $2.40 | +20.7% |
| 2025Q2 | $1.92 | $2.19 | +14.1% |
| 2025Q1 | $1.73 | $1.81 | +4.4% |
| 2024Q4 | $1.79 | $2.21 | +23.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*